Borosil Scientific Ltd

Borosil Scientific Ltd

₹ 183 0.52%
22 Nov 12:37 p.m.
About

Since 1962, Borosil is into finest quality scientific and laboratory glassware, which is used in Quality Control in pharmaceutical industries, Food and Soil testing, Microbiology, and Biotechnology.[1]

Key Points

Borosil Group[1]
The company is a part of Borosil group which is into glassware and laboratory products,
scientific & industrial glassware, consumer & kitchenware products, and solar glass products. Group comprises of:
1. Borosil Renewables Ltd
2. Borosil Ltd
3. Borosil Scientific Ltd

  • Market Cap 1,627 Cr.
  • Current Price 183
  • High / Low 230 / 137
  • Stock P/E 48.3
  • Book Value 44.8
  • Dividend Yield 0.00 %
  • ROCE 11.0 %
  • ROE 8.58 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 4.11 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
90.79 79.71 84.35 88.42 102.66 93.40 87.04
71.55 73.44 71.85 75.01 83.75 82.44 73.72
Operating Profit 19.24 6.27 12.50 13.41 18.91 10.96 13.32
OPM % 21.19% 7.87% 14.82% 15.17% 18.42% 11.73% 15.30%
1.09 1.04 1.35 1.35 1.65 2.14 1.91
Interest 0.65 0.30 0.27 0.34 0.51 0.24 0.18
Depreciation 3.16 3.37 3.50 4.12 4.07 4.20 4.23
Profit before tax 16.52 3.64 10.08 10.30 15.98 8.66 10.82
Tax % 30.15% -15.11% 23.12% 27.67% 24.47% 25.29% 28.93%
11.55 4.20 7.74 7.45 12.07 6.47 7.69
EPS in Rs 0.84 1.36 0.73 0.87
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024 TTM
323 352 372
272 301 315
Operating Profit 51 51 57
OPM % 16% 15% 15%
5 5 7
Interest 1 1 1
Depreciation 12 15 17
Profit before tax 43 40 46
Tax % 29% 21%
30 31 34
EPS in Rs 3.54 3.80
Dividend Payout % 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 9%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 3%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.29 9 9
Reserves 352 374 389
11 11 7
69 82 65
Total Liabilities 432 477 470
150 159 153
CWIP 8 1 3
Investments 32 41 47
241 275 267
Total Assets 432 477 470

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024
-57 32
49 -20
7 -1
Net Cash Flow 0 11

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024
Debtor Days 46 55
Inventory Days 325 256
Days Payable 70 102
Cash Conversion Cycle 301 208
Working Capital Days 200 190
ROCE % 11%

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024
67.92% 67.86%
0.38% 0.37%
0.15% 0.01%
31.54% 31.74%
No. of Shareholders 62,35461,201

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents